Skip to main content
PMC home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 3):95–97.

Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine.

P H Evans 1
PMCID: PMC1543584  PMID: 122685

Full text

PDF
95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aylward M. A review of possible mechanisms of action of the antirheumatic drug, alclofenac. Curr Med Res Opin. 1975;3(5):249–263. doi: 10.1185/03007997509114775. [DOI] [PubMed] [Google Scholar]
  2. Ballantyne F. C., Fleck A., Dick W. C. Albumin metabolism in rheumatoid arthritis. Ann Rheum Dis. 1971 May;30(3):265–270. doi: 10.1136/ard.30.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CAPLAN A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax. 1953 Mar;8(1):29–37. doi: 10.1136/thx.8.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CAPLAN A., PAYNE R. B., WITHEY J. L. A broader concept of Caplan's syndrome related to rheumatoid factors. Thorax. 1962 Sep;17:205–212. doi: 10.1136/thx.17.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Creighton T. E. Renaturation of the reduced bovine pancreatic trypsin inhibitor. J Mol Biol. 1974 Aug 15;87(3):563–577. doi: 10.1016/0022-2836(74)90104-1. [DOI] [PubMed] [Google Scholar]
  6. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  7. Evans P. H. Serum sulphydryl levels in rheumatoid patients treated with alclofenac. Curr Med Res Opin. 1975;3(5):268–275. doi: 10.1185/03007997509114777. [DOI] [PubMed] [Google Scholar]
  8. Famaey J. P., Whitehouse M. W. Interaction between nonsteroidal anti-inflammatory drugs and biological membranes-IV. Effects of nonsteroidal anti-inflammatory drugs and of various ions on the availability of sulfhydryl groups on lymphoid cells and mitochondrial membranes. Biochem Pharmacol. 1975 Sep 1;24(17):1609–1615. doi: 10.1016/0006-2952(75)90088-x. [DOI] [PubMed] [Google Scholar]
  9. Gerber D. A. Copper-catalyzed thermal aggregation of human gamma-globulin. Inhibition by histidine, gold thiomalate, and penicillamine. Arthritis Rheum. 1974 Jan-Feb;17(1):85–91. doi: 10.1002/art.1780170113. [DOI] [PubMed] [Google Scholar]
  10. Jaffe I. A., Merryman P. Effect of increased serum sulphydryl content on titre of rheumatoid factor. Ann Rheum Dis. 1968 Jan;27(1):14–18. doi: 10.1136/ard.27.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson P. M., Watkins J., Scopes P. M., Tracey B. M. Differences in serum IgG structure in health and rheumatoid disease. Circular dichroism studies. Ann Rheum Dis. 1974 Jul;33(4):366–370. doi: 10.1136/ard.33.4.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kosaka S. Serum sulfhydryl levels and rheumatoid factors in rheumatoid arthritis. Tohoku J Exp Med. 1970 Apr;100(4):349–358. doi: 10.1620/tjem.100.349. [DOI] [PubMed] [Google Scholar]
  13. LORBER A., PEARSON C. M., MEREDITH W. L., GANTZ-MANDELL L. E. SERUM SULFHYDRYL DETERMINATIONS AND SIGNIFICANCE IN CONNECTIVE TISSUE DISEASES. Ann Intern Med. 1964 Sep;61:423–434. doi: 10.7326/0003-4819-61-3-423. [DOI] [PubMed] [Google Scholar]
  14. Lorber A., Bovy R. A., Chang C. C. Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations. Metabolism. 1971 May;20(5):446–455. doi: 10.1016/0026-0495(71)90120-x. [DOI] [PubMed] [Google Scholar]
  15. Moore W. E., Foster J. F. The microheterogeneity of plasma albumins. IV. Evidence from reversible denaturation that three-dimensional folding is not responsible for microheterogeneity. Biochemistry. 1968 Oct;7(10):3409–3417. doi: 10.1021/bi00850a015. [DOI] [PubMed] [Google Scholar]
  16. Okubo A. On the conformation around the sulfhydryl group in human serum albumin. J Biochem. 1969 Jun;65(6):879–888. doi: 10.1093/oxfordjournals.jbchem.a129092. [DOI] [PubMed] [Google Scholar]
  17. Planas-Bohne F. Untersuchungen zur Bildung gemischter Disulfide zwischen D-Penicillamin und Serumproteinen. Res Exp Med (Berl) 1973 Nov 23;161(4):289–297. doi: 10.1007/BF01851452. [DOI] [PubMed] [Google Scholar]
  18. Sorenson J. R. Copper chelates as possible active forms of the antiarthritic agents. J Med Chem. 1976 Jan;19(1):135–148. doi: 10.1021/jm00223a024. [DOI] [PubMed] [Google Scholar]
  19. Sugiura Y., Tanaka H. Evidence for a ternary complex containing albumin, copper, and penicillamine. Mol Pharmacol. 1972 Mar;8(2):249–255. [PubMed] [Google Scholar]
  20. Thomas J., Evans P. H. Serum protein changes in coal workers' pneumoconiosis. Clin Chim Acta. 1975 Apr 16;60(2):237–247. doi: 10.1016/0009-8981(75)90132-1. [DOI] [PubMed] [Google Scholar]
  21. Watkins J., Swannell A. J. Catabolism of human serum IgG in health, rheumatoid arthritis, and active tuberculous disease. Possible influence of IgG structure. Ann Rheum Dis. 1973 May;32(3):247–250. doi: 10.1136/ard.32.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wilding P., Kendall M. J., Holder R., Grimes J. A., Farr M. The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis. Clin Chim Acta. 1975 Oct 15;64(2):185–194. doi: 10.1016/0009-8981(75)90200-4. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES